NEW YORK (GenomeWeb News) – Shares of Vermillion fell roughly 34 percent during June, pulling back from sharp gains over the previous month, and leading decliners in the GenomeWeb Daily News Index for the month.

The firm was one of three firms in the Index to see their shares fall more than 25 percent, as GenMark Diagnostics declined nearly 31 percent and Nanosphere was down 27 percent month over month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.